Eargo, Inc. (EAR) Research

Eargo, Inc., a medical device firm, strives to improve the quality of life for individuals experiencing hearing impairment across the United States. The company focuses on developing and distributing hearing aids, utilizing both direct-to-consumer and extensive omni-channel sales approaches. Founded in 2010, the organization initially operated as Aria Innovations, Inc., before officially changing its name to Eargo, Inc. in November 2014. Its primary corporate hub is located in San Jose, California.

Market snapshot

Symbol
EAR
Price
$2.57
Day change
-4.10%
Market cap
$53.4M
P/E ratio
-0.06x
52-week range
1.465-8.48
Sector
Healthcare
Industry
Medical - Devices

Peer companies

  • Akso Health Group (AHG)
  • Aerpio Pharmaceuticals, Inc. (ARPO)
  • bluebird bio, Inc. (BLUE)
  • GlucoTrack, Inc. (GCTK)
  • Kronos Bio, Inc. (KRON)
  • Lifeward Ltd. (LFWD)
  • enVVeno Medical Corporation (NVNO)
  • Singular Genomics Systems, Inc. (OMIC)

Recent insider activity

  • Brownie William — D-Return (38 shares) on 2024-02-16
  • Brownie William — D-Return (2206 shares) on 2024-02-16
  • Brownie William — D-Return (258 shares) on 2024-02-16
  • Narula Onkarr — D-Return (5000 shares) on 2024-02-16
  • Wu David James — D-Return (5000 shares) on 2024-02-16

Open Eargo, Inc. (EAR) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.